A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
The Cornell Center for Health Equity has launched its racial allyship training course, providing anyone who wants to learn to be a better ally with essential skills and tools they can use in their personal and professional lives.
Pauline Flaum-Dunoyer has interviewed more than a dozen women physicians of color, and donated the recordings and transcripts to NewYork-Presbyterian/Weill Cornell Medicine, where their legacies will be preserved for future generations.
Strokes cause changes in gene activity in affected small blood vessels in the brain, changes that may be targetable with existing or future drugs to mitigate brain injury or improve stroke recovery, according to Weill Cornell Medicine scientists.
Members of the Cornell entrepreneurial community gathered to celebrate a successful first year of the BioEntrepreneurship Initiative at the program’s culminating workshop on March 18 in Midtown Manhattan.
Using a biomaterials-based organoid, a multi-institution team led by Matt DeLisa of Cornell Engineering was able to assess the strength of the immune response to a glycoengineered vaccine in days, instead of months.
People with autism spectrum disorder can be classified into four distinct subtypes based on their brain activity and behavior, according to a study from Weill Cornell Medicine investigators.
